Saniona AB (publ)

SSE:SANION.ST

2.1 (SEK) • At close February 20, 2024
Bedrijfsnaam Saniona AB (publ)
Symbool SANION.ST
Munteenheid SEK
Prijs 2.105
Beurswaarde 225,801,245
Dividendpercentage 0%
52-weken bereik 1.962 - 10.526
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jorgen Drejer Ph.D.
Website https://www.saniona.com

An error occurred while fetching data.

Over Saniona AB (publ)

Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical

Vergelijkbare Aandelen

Sprint Bioscience AB (publ) logo

Sprint Bioscience AB (publ)

SPRINT.ST

0.876 SEK

AlzeCure Pharma AB (publ) logo

AlzeCure Pharma AB (publ)

ALZCUR.ST

2.49 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)